Abcellera Biologics Inc. Stock
€2.74
Your prediction
Abcellera Biologics Inc. Stock
Pros and Cons of Abcellera Biologics Inc. in the next few years
Pros
Cons
News
![AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024: https://mms.businesswire.com/media/20210119006096/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXZxVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ffa9917eb0619c67dbd608135a7598a691a7ab4e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AbCellera_Full_Colour_RGB_1.jpg?locale=us)
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time)
![AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024: https://mms.businesswire.com/media/20210119006096/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXZxVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ffa9917eb0619c67dbd608135a7598a691a7ab4e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AbCellera_Full_Colour_RGB_1.jpg?locale=us)
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific
![AbCellera Reports Q1 2024 Business Results: https://mms.businesswire.com/media/20210119006096/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXZxVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ffa9917eb0619c67dbd608135a7598a691a7ab4e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AbCellera_Full_Colour_RGB_1.jpg?locale=us)
AbCellera Reports Q1 2024 Business Results
AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.